Development of Fluorine-Free Tantalum Carbide Mxene Hybrid Structure as a Biocompatible Material for Supercapacitor Electrodes
20240199431 ยท 2024-06-20
Inventors
Cpc classification
C01B21/06
CHEMISTRY; METALLURGY
Y02E60/13
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
International classification
C01B21/06
CHEMISTRY; METALLURGY
Abstract
A new fluorine-free tantalum carbide MXene-tantalum oxides (TTO) nanostructure was developed as a biocompatible electrode material for size-sensitive applications. The TTO hybrid structure is biocompatible with different types of human cells, and offers excellent volumetric capacitance, energy density, power density, and cyclability when assembled into a symmetric supercapacitor. The TTO offers high promise for future biomedical energy storage devices.
Claims
1. A method for synthesizing a two-dimensional transition metal carbides and nitrides (MXenes)-metal oxide hybrid structure material comprising: (a) providing a quantity of a MAX phase powder, where M represents an early transition metal, A represents an A group element and X represents carbon or nitrogen; (b) chlorinating the MAX phase powder, thereby solubilizing the A group element and forming a chlorinated MX powder; (c) etching the chlorinated MX powder with an oxide source, thereby forming an exfoliated nanocomposite; and (d) heating the exfoliated nanocomposite, thereby forming the MXenes-M-oxide hybrid structure material.
2. The method according to claim 1 wherein the early transition metal is tantalum.
3. The method according to claim 1 wherein the MAX phase powder is selected from the group consisting of tantalum aluminium carbide (Ta.sub.4AlC.sub.3), vanadium aluminium carbide (V.sub.4AlC.sub.3), niobium aluminium carbide (Nb.sub.2AlC.sub.3 and Nb.sub.2AlC), titanium aluminium carbide (Ti.sub.3AlC.sub.2), zirconium aluminium carbide (Zr.sub.2AlC), and halfmium aluminium carbide (Hf.sub.3AlC.sub.2).
4. The method according to claim 1 wherein the MAX phase powder is tantalum aluminium carbide.
5. The method according to claim 1 wherein the MAX phase powder is chlorinated by treatment with HCl or HClO.
6. The method according to claim 1 wherein the MAX phase powder is chlorinated by treatment with HCl.
7. The method according to claim 6 wherein the HCl is 6M HCl.
8. The method according to claim 1 wherein the oxide source is selected from the group consisting of: KOH, NaOH, H.sub.2O.sub.2 and LiOH.
9. The method according to claim 1 wherein the oxide source is KOH.
10. The method according to claim 1 wherein the exfoliated nanocomposite is heated at about 200 to about 500 C, for about 2 to about 4 hrs.
11. The method according to claim 1 wherein the exfoliated nanocomposite is heated at about 220C for about 2 hrs.
12. A MXenes-oxide hybrid structure material prepared according to the method of claim 1.
13. A MXenes-oxide hybrid structure material.
14. The MXenes-oxide hybrid structure material according to claim 13 wherein the MXenes-oxide hybrid structure material is a MXene-tantalum oxides hybrid structure material.
15. (canceled)
16. (canceled)
17. (canceled)
18. (canceled)
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0017] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned hereunder are incorporated herein by reference.
[0018] Application of nontoxic two-dimensional transition-metal carbides (MXenes) has recently gained ground in bioelectronics. In group-4 transition metals, tantalum possesses enhanced biological and physical properties compared to other MXene counterparts. However, the application of tantalum carbide for bioelectrodes has not yet been explored. Here, we demonstrate fluorine-free exfoliation and functionalization of tantalum carbide MAX-phase to synthesize a novel Ta.sub.4C.sub.3T.sub.x MXene-tantalum oxide (TTO) hybrid structure through an innovative, facile and inexpensive protocol. Additionally, we report the application of TTO composite as an efficient biocompatible material for supercapacitor electrodes. The TTO electrode displays long-term stability over 10,000 cycles with capacitance retention of over 90% and volumetric capacitance of 447 F cm.sup.?3 (194 F g.sup.?1) at 1 mV s.sup.?1. Furthermore, TTO shows excellent biocompatibility with human-induced pluripotent stem cells-derived cardiomyocytes, neural progenitor cells, fibroblasts, and mesenchymal stem cells. More importantly, the electrochemical data show that TTO outperforms most of the previously reported biomaterials-based supercapacitors in terms of gravimetric/volumetric energy and power densities. Therefore, TTO hybrid structure may open a gateway as a bioelectrode material with high energy-storage performance for size-sensitive applications such as cardiac pacemakers, neurostimulators and cochlear implants.
[0019] According to an aspect of the invention, there is provided a method for synthesizing a two-dimensional transition metal carbides and nitrides (MXenes)-oxide hybrid structure material comprising: [0020] (a) providing a quantity of a MAX phase powder, where M represents an early transition metal, A represents an A group element and X represents carbon or nitrogen; [0021] (b) chlorinating the MAX phase powder, thereby solubilizing the A group element and forming a chlorinated MX powder; [0022] (c) etching the chlorinated MX powder with an oxide source, thereby forming an exfoliated nanocomposite; and [0023] (d) heating the exfoliated nanocomposite, thereby forming the MXenes-M-oxide hybrid structure material.
[0024] The MAX phase powder may be any suitable MAX phase powder known in the art, for example but by no means limited to the group consisting of tantalum aluminium carbide (Ta.sub.4AlC.sub.3), vanadium aluminium carbide (V4AlC.sub.3), niobium aluminium carbide (Nb.sub.2AlC.sub.3 and Nb.sub.2AlC), titanium aluminium carbide (Ti.sub.3AlC.sub.2), zirconium aluminium carbide (Zr.sub.2AlC), and hafnium aluminium carbide (Hf.sub.3AlC.sub.2).
[0025] In some embodiments of the invention, the MAX phase powder is tantalum carbide.
[0026] The MAX phase powder may be chlorinated using any suitable chlorination method known in the art, for example but by no means limited to, HCl and/or HClO.
[0027] In some embodiments of the invention, the MAX phase powder is chlorinated by treatment with HCl, for example, with 6M HCl.
[0028] The oxide source may be any suitable oxide source known in the art, for example but by no means limited to KOH, NaOH, H.sub.2O.sub.2 and/or LiOH.
[0029] In some embodiments of the invention, the oxide source is KOH.
[0030] The exfoliated nanocomposite may be heated at a temperature between from about 200 to about 500 C, for a time period of from about 2 to about 4 hrs. In some embodiments, the exfoliated nanocomposite may be heated at about 220C for about 2 hrs, wherein about indicates plus/minus 10%.
[0031] According to another aspect of the invention, there is provided a MXenes-oxide hybrid structure material prepared according to the above-described method.
[0032] In some embodiments of the invention, the MXenes-oxide hybrid structure material is used in a bioelectrode material.
[0033] In some embodiments of the invention, the MXenes-oxide hybrid structure material is used in a supercapacitor electrode.
[0034] This study reported the first fluorine-free synthesis and application of Ta.sub.4C.sub.3T.sub.x MXene-tantalum oxides hybrid structure material for energy storage applications. The TTO-based electrode showed excellent volumetric capacitance compared to previously reported biocompatible electrodes. Furthermore, the TTO hybrid structure is highly biocompatible with different types of human cells, which is highly beneficial for future applications in bioelectronics and biosensors. Finally, when assembled into a symmetric supercapacitor, the TTO hybrid structure material possessed high energy/power densities and long-term cyclability. The stability of TTO electrodes was estimated to be over 10,000 cycles.
[0035] The invention will now be further explained and/or elucidated by way of examples; however, the invention is not necessarily limited to or by the examples.
Example 1Fabrication of TTO Hybrid Structure
[0036] Specifically, we employed an innovative fluorine-free etching method to prepare TTO hybrid nanostructure from raw and bulk material. Recently, application of an alkaline-induced method for removal of Al from the Ti.sub.3AlC.sub.2 MAX phase to synthesize Ti.sub.3C.sub.2T.sub.x MXene was reported [31]. However, the main challenge in etching the Al layer from MAX phase in alkaline media is the blocked/slow kinetic reactions due to the formation of unwanted oxide/hydroxide layers on the MXene surface [32]. To address this, we utilized our innovative alkaline-based etching method to prepare the TTO via a two-step acidic/alkaline (HCl/KOH) treatment. Briefly, Ta.sub.4AlC.sub.3 MAX phase powder was treated sequentially with 6M hydrochloric acid (HCl) solution and 6M potassium hydroxide (KOH) solution to synthesize an exfoliated nanocomposite. This led to formation of multilayered oxidized Ta.sub.4C.sub.3T.sub.x nanosheets anchored with Ta-oxide particles. These were subsequently subjected to thermal treatment at 220? C. under moderate air heating for further functionalization and oxidation, resulting in the formation of final TTO hybrid structure. The step-by-step schematic model for the synthesis and functionalization of the mixed-dimensional TTO nanocomposite is shown in
[0037] In our proposed mechanism of reaction (
Example 2Characterization of TTO Hybrid Structure
[0038] The scanning electron microscopic (SEM) images of the functionalized Ta.sub.4C.sub.3T.sub.x MXene nanosheets prior to thermal treatment are presented in
[0039] Furthermore, field-emission SEM images of the oxidized Ta.sub.4C.sub.3T.sub.x MXene and TTO hybrid structure revealed a slight decrease in the wall-to-wall interlayer space of MXene nanosheets after thermal treatment.
[0040] The high-resolution transmission electron microscopy (TEM) of oxidized Ta.sub.4C.sub.3T.sub.x MXene and the TTO hybrid structure revealed that individual nanoparticles are approximately 5 nm in diameter and cluster to form larger decorations seen in the SEM images (
[0041] The selected area electron diffraction (SAED) patterns of TTO hybrid structure displayed a higher degree of crystalline structure with well-defined hexagonal planes compared to oxidized Ta.sub.4AlC.sub.3 MXene samples. Together these observations provide robust evidence that the innovative fluorine-free exfoliation and functionalization protocol employed in the current study has worked successfully to synthesize TTO nanostructure from the Ta.sub.4AlC.sub.3 MAX phase.
[0042] The physicochemical properties of materials were further evaluated by X-ray photoelectron spectroscopy (XPS), energy-dispersive X-ray spectroscopy (EDS), SAED, and X-ray diffraction (XRD) analysis. XPS was used to characterize the structural transformation of TaAlC.sub.3 MAX phase to oxidized Ta.sub.4C.sub.3T.sub.x MXene and TTO hybrid structure. Comparison of survey spectra showed a significant change in the elemental composition of materials during the synthesis process. In particular, characteristic Al 2p peaks of TaAlC.sub.3 MAX phase were significantly decreased in the TTO hybrid structure. High resolution XPS spectra of TTO hybrid structure showed well-defined characteristics of Ta.sub.4C.sub.3T.sub.x MXene. A comparison between Al 2p spectra of the Ta.sub.4AlC.sub.3 MAX phase and TTO confirmed effective elimination of Al layer, with more than 84% of elemental Al removed during the hybrid synthesis process (
[0043] As is known to those of skill in the art, HF is known to be an effective etchant to synthesize MXene nanosheets from bulk materials. However, the toxicity of HF limits the biomedical applications of MXene products synthesized using HF. In contrast, HCl is a milder acid, but, despite this, the results that we obtained with our innovative and facile method that employed HClKOH for etching of MAX phase to synthesize TTO, were surprisingly comparable with what has been reported with HF. Therefore, we were pleasantly surprised with the outcome as the process described herein avoids the complexities associated with the handling of HF while producing a comparable product that has the significant advantage of being biocompatible.
[0044] The Ta 4f, O Is, and C Is spectra demonstrated a change in the degree of exfoliation and functionalization when converting Ta.sub.4AlC.sub.3 MAX phase to TTO hybrid structure (
[0045] Finally, the successful synthesis of TTO hybrid structure using the fluorine-free process was further corroborated by EDS and XRD. The EDS elemental analysis demonstrated successful extraction of Al from the structure of Ta.sub.4AlC.sub.3 MAX phase with a decrease in the atomic percentage of Al from 20.57% to 11.31%. The average weight percentage of Al similarly decreased from 12.64% to 4.43%. Concurrently, the atomic percentage of oxygen increased from 20.03% to 30.05%. The histogram also confirmed the absence of F, Cl, and K in the final composition of the TTO hybrid structure. Specifically, as can be seen, the Al percentage has been reduced significantly, down to acceptable levels.
[0046] The XRD pattern of the Ta.sub.4AlC.sub.3 bulk material was typical with standard peaks at their expected 2? values [22]. In agreement with the previous observations, peaks originating from the aluminum-containing MAX phase were significantly decreased after fluorine-free etching and exfoliation by the HCl/KOH process. One of the Ta.sub.4AlC.sub.3 peaks at around 16.5? 20 was entirely removed in the TTO hybrid structure. Additionally a minor contamination peak ascribed to Ta.sub.2C with the reflection at 2??50? was absent in the XRD spectrum of TTO hybrid structure [36]. Furthermore, a newly emerged (002) peak at around 7? 2? corresponds to an aluminum-etched tantalum carbide-tantalum oxide material with the enlarged lattice parameters. Additional downshifts are also observed in the XRD spectra of the TTO hybrid structure due to increased carbon lattice spacing after the acid/alkaline treatment. Lastly, characteristic small peaks corresponding to tantalum oxide particles anchored on the MXene surface were also observed in the structure of the TTO. Together these findings support the successful synthesis and functionalization of layered TTO hybrid structure using a fluorine-free exfoliation and functionalization protocol.
Example 3Specific Surface Area of TTO Hybrid Structure
[0047] The surface area of carbon-based nanomaterials is an important determinant of their electrochemical properties. The specific surface area of Ta.sub.4AlC.sub.3 MAX phase, oxidized Ta.sub.4C.sub.3T.sub.x MXene, and TTO hybrid structure was determined using Brunauer-Emmett-Teller (BET) nitrogen adsorption isotherms (
[0048] Consistent with Barrett-Joyner-Halenda (BJH) theory, the total pore volume was increased by approximately 14-fold in the TTO hybrid structure when compared with Ta.sub.4AlC.sub.3 MAX phase. The average pore diameter, however, decreased from 81.15 nm in Ta.sub.4AlC.sub.3 MAX phase to 32.25 nm in oxidized Ta.sub.4C.sub.3T.sub.x MXene and 24.42 nm in TTO hybrid structure (
Example 4Electrochemical Properties of TTO Hybrid Electrode
[0049] The electrochemical properties of the TTO hybrid structure were characterized by two-electrode system. The TTO hybrid structure and oxidized Ta.sub.4C.sub.3T.sub.x MXene based electrodes were fabricated using a 8:1:2 weight ratio of MXene material, Super P carbon black and polyvinylidene fluoride (PVDF). The cyclic voltammetry (CV) and galvanostatic charge/discharge (GCD) were measured in the presence of a polyvinyl alcohol/phosphoric acid (PVA/H.sub.3PO.sub.4) solid electrolyte. The CV profiles of the oxidized Ta.sub.4C.sub.3T.sub.x MXene electrode and the TTO hybrid structure electrode were quasi-rectangular at scan rates ranging from 1 to 100 mV s.sup.?1 with near mirror symmetry among all CV profiles, indicating that the majority of capacitance is associated with the electric double layer capacitance (EDLC) mechanism (
[0050] The electrochemical impedance spectroscopy (EIS) analysis was used to investigate the ion-diffusion/transport resistance of the TTO electrode in the frequency range of 0.01 Hz to 200 kHz at open-circuit-potential (OCP) measurements. The impedance spectra of the oxidized Ta.sub.4C.sub.3T.sub.x MXene electrode and the TTO electrode form a small arc and a spike at the higher and lower frequency regions respectively. The TTO hybrid structure electrode clearly showed lower electrolyte resistance than the oxidized Ta.sub.4C.sub.3T.sub.x MXene electrode (
[0051] The electrochemical mechanism measurements of TTO hybrid structure were further investigated based on the following equation:
[0052] This equation includes two scan rate-related terms at a fixed scan rate and potential. The k.sub.1v term is attributed to the current density contributed by the fast-kinetics process in both electric double-layer capacitance and Faraday pseudocapacitance [4]. The k.sub.2v.sup.1/2 term is related to the current density contributed by a slow diffusion-controlled process [41]. Both constants, k.sub.1 and k.sub.2 are obtained from a different form of the above equation in a log-log plot, as shown below.
[0053] The contribution of the fast-kinetics process for various sweep rates is shown in
[0054] These findings were confirmed with measurements from a three-electrode system using the same electrolyte against an Ag/AgCl reference electrode. The results further elucidated the pseudocapacitance effect of Ta.sub.2O.sub.5 and other oxygen-containing functional groups in acidic electrolytes. The TTO hybrid structure electrode exhibited electric double layer capacitance (EDLC) behavior with quasi-pseudocapacitance behavior. The oxidized surface of TTO may significantly increase the wettability and enlarge the ion-accessible surface area, facilitating rapid ion diffusion/transportation into the internal pores. The possible redox reaction of Ta.sub.4C.sub.3T.sub.x MXene in an acidic medium is depicted in Equation 3 [42].
The possible redox reaction of Ta.sub.2O.sub.5 on Ta.sub.4C.sub.3T.sub.x MXene in an acidic medium is shown in Equation 4 [43].
[0055] The normalized capacitance value for the two-electrode system included contributions of two TTO hybrid structure electrodes, while the three-electrode system used a single TTO hybrid structure electrode. Therefore, the values derived from three-electrode measurements should be approximately two times of the values obtained from two-electrode measurements (
Example 5Ragone Plot of TTO Electrode Supercapacitor
[0056] Next, we wanted to evaluate and compare the performance of the TTO hybrid structure electrode with literature-reported organic/inorganic energy storage materials for bio-implantable applications. Ideally, the best bioelectrode materials for implantable supercapacitors should possess excellent energy and power density in a single product, while having low individual component toxicity in case of damage and uncontrolled failure. In particular, currently used lithium-ion batteries and their toxic electrolytes in cardiac pacemakers, neurostimulators, cochlear implants and spinal cord stimulators have been reported to seriously jeopardize patient safety in cases of premature failure [44,45].
[0057] In the current study, Ragone plots are presented to compare the volumetric performance of the TTO hybrid structure supercapacitor with several previously-reported biocompatible supercapacitors and MXene-based electrode supercapacitors (
[0058] In addition to its excellent capacitance properties, the TTO displayed outstanding long-term stability over 10,000 cycles with capacitance retention maintained over 90% of the initial performance (
Example 6Biocompatibility of TTO
[0059] We also investigated the biocompatibility of oxidized TTO electrode with human induced pluripotent stem cells (hiPSC)-derived cardiomyocytes, neural progenitor cells, and fibroblasts. The hiPSC-derived cells were obtained using our established differentiation protocols [55]. When MXene-based materials (at a concentration 50 ?g mL.sup.?1) were co-cultured with these cells for 24 hours, assessment of cytotoxicity using the WST-1 assay showed that all forms of the Ta.sub.4C.sub.3T.sub.x MXenes were compatible with cardiomyocytes, neural progenitor cells, and fibroblasts (
[0060] Additionally, TTO-based bio-electrodes may also be beneficial in the development and post-delivery monitoring of functional cell-based tissue constructs. Bone marrow-derived mesenchymal stem cells (MSC), a commonly used cell type in tissue engineering, were found to be biocompatible with all forms of Ta.sub.4C.sub.3T.sub.x MXene-based samples used in this study. When co-cultured with materials for 72 hours, assessment of cytotoxicity by LDH assay showed excellent residual viability of cells in all groups as there were no significant differences in cytotoxicity between different MXene groups and the control group (
Example 7Experimental Section
[0061] Fluorine-Free Synthesis of Oxidized Ta.sub.4C.sub.3T.sub.x and TTO Hybrid Structure
[0062] Ta.sub.4C.sub.3T.sub.x MXene nanosheets were partially exfoliated using hydrochloric acid (HCl). To do so, Ta.sub.4AlC.sub.3 MAX Phase powder was incubated in 6M solution of HCl in water at 37? C. for 72 hours in a shaking incubator at 260 rpm. The precipitates were collected after washing with ultrapure distilled water by spinning at 5,000 rpm for 5 minutes each. The precipitates were freeze dried for 48 hours and subsequently air dried at 60? C. The complete etching, exfoliation, and surface modification of the obtained material (dry powder) was achieved by treating it with potassium hydroxide (KOH, 6M) at room temperature for 90 hours. The edge exfoliation of specimens was obtained by centrifugation at 5,000 rpm followed by several washing steps and vacuum lyophilization (?80? C.& ?54? C.) for 48 hours to avoid uncontrolled oxidization. The powder was then double-dried in an atmospheric oven at 50? C. for 48 hours. The resultant nanocomposite obtained at this step was labeled as oxidized Ta.sub.4C.sub.3T.sub.x at room temperature (22? C.). For further functionalization and oxidation, the treated Ta.sub.4C.sub.3T.sub.x nanosheets were subjected to thermal treatment at 220? C. for 2 hours under moderate air heating and labeled as TTO hybrid structure (220? C.).
Physicochemical Characterization
[0063] The structural properties of materials were characterized using an FEI Nova NanoSEM 450 (Thermo Fisher Scientific), FEI Talos F200X S/TEM (Thermo Fisher Scientific), Thermo Nicolet Nexus 870, and Kratos Axis Ultra X-ray photoelectron spectroscopy (XPS) at the Manitoba Institute of Materials (MIM), University of Manitoba, Winnipeg, Canada. The SEM samples were mounted on pin stubs using carbon tape and coated with a gold-palladium (AuPd) coating to enable high magnifications. X-ray diffraction peaks of powdered samples were collected in the range from 5 to 80? 2-theta using continuous scan mode with a scan rate of 3?/minute and report interval of 0.05?. The measurement of specific surface area of the materials was determined by the Brunauer-Emmett-Teller (BET) analysis.
Electrode Fabrication, Electrical and Electrochemical Measurements
[0064] The TTO electrodes were fabricated using the following procedures. Each TTO hybrid structure electrode was synthesized using 8:1:2 ratio of TTO hybrid structure (160 mg), Super P carbon black (20 mg) and PVDF (40 mg) in N-methyl-2-pyrrolidone (NMP) solvent. The slurry prepared by mixing these components was brushed on a carbon paper and pressed after drying in a vacuum oven at 70? C. for 24 hours. The capacitance properties of the prepared TTO electrodes were characterized by using two- and three electrode systems at room temperature.
[0065] Cyclic voltammetry and the constant current charge-discharge measurements were performed on Autolab electrochemical workstation (PGSTAT302 N model) and CH Instrument 640E Bipotentiostat. The specific capacitance for cyclic voltammetry-based measurement was calculated according to the following equation:
where C, I, v, m, and ?V are the specific capacitance, current, scan rate (V s.sup.?1), weight of electrode, and scanning potential window respectively. The constant current charge-discharge test was performed for specific capacitance. Values were calculated using the following equation:
where I, ?t, and ?V are respectively discharge current, discharge time, and discharge potential window..sup.[38] The energy density and power density of the device were calculated as E=C(?V).sup.2/7.2 and P=3600 E/?t, where E and P, are energy and power densities, respectively. Using the density of the packed electrolyte (2.3?10.sup.?3 kg cm.sup.?3), the volumetric energy density (E.sub.vol) and volumetric power density (P.sub.vol) were calculated using the following equations:
[0066] The CV and GCD measurements were performed with all solid-state two-electrode system in the presence of polyvinyl alcohol (PVA) and H.sub.3PO.sub.4 gel electrolyte. For this, a gel electrolyte solution was prepared by mixing 10 g of PVA and 10 g of H.sub.3PO.sub.4 in 100 mL of deionized water at 85? C. The solution was incubated in an oven at 40? C. for a week to solidify. A thin layer of the PVA/H.sub.3PO.sub.4 electrolyte was sandwiched between two active electrodes of the same size and mass and subjected to a hot-pressing step at 10.9 psi. The copper (Cu) foils were attached to the other side of the TTO electrode to be used as the current collector. For Ragone plots we used the total mass of the packaged TTO-based supercapacitor (959 mg) including TTO hybrid structure electrodes, electrolyte, carbon blacks, and PVDF to calculate and evaluate the total energy or power densities.
[0067] The capacitance of TTO-based electrodes was further characterized by using a three-electrode system at room temperature with phosphoric acid (H.sub.3PO.sub.4) solution as electrolyte. The platinum (Pt) and silver/silver chloride (Ag/AgCl) were used in the experiment as the counter electrode and the reference electrode, respectively.
Density Measurement
[0068] The gravimetric capacitance of the Ta.sub.4C.sub.3T.sub.x MXene/tantalum oxides (TTO) electrode is converted to volumetric capacitance by Archimedes' Principle. The density of TTO electrode was calculated using the following equation:
where W.sub.a, W.sub.ax, ? and ?.sub.ax are the weight of the sample in air, weight of the sample in the auxiliary liquid of known density, the density of the sample and auxiliary liquid, respectively.
Assessment of Energy Storage Performance of TTO Supercapacitor
[0069] The energy storage performance of TTO was assessed using a light-emitting diode (LED). The TTO electrode in the supercapacitor was charged and was connected in an LED output and the performance was observed.
Induced Pluripotent Stem Cells Generation, Culture and Differentiation
[0070] Human induced pluripotent stem cells (hiPSCs) were generated from peripheral blood mononuclear cells (PBMC) isolated from human blood (collected from healthy individuals). All protocols were approved by the University of Manitoba Health Research Ethics Board (B2015:025, HS18974). To reprogram PBMCs toward iPSCs a commercial reprogramming kit CytoTune?-iPS 2.0 Sendai Reprogramming Kit was used (A16517, ThermoFisher Scientific, US). The detailed procedure is described in previously published studies [56,57].
[0071] The hiPSCs were cultured in TeSR?-E8? (05990, STEMCELL Technologies) on Geltrex (A1413302, Gibco) and allowed to differentiate toward fibroblast, cardiomyocytes (CMs) and neural progenitor cells (NPCs) using our previously published protocols [55]. Briefly, embryoid bodies (EBs) were prepared in suspension in low attachment plates (174932, Thermo Scientific) and plated onto gelatin-coated plates on Day 8 (PMEF-CFL-P1, EMD Millipore). They were allowed to differentiate spontaneously toward fibroblasts, which were manually dissected from the culture plate and characterized by staining for HSP47 (ab77609, Abcam) and FSP (ab11333, Abcam). The cell populations were enriched over several passages to ensure a pure fibroblast population.
[0072] The hiPSCs were differentiated to cardiomyocytes using following protocol: iPSCs (>passage 20) were passaged onto Geltrex-coated plates using Versene Solution (15040066, Gibco) and grown till the cells reached ?85% confluency. The medium was replaced with CDM3, consisting of RPMI 1640 (61870036, Gibco) supplemented with 500 ?g mL.sup.?1 recombinant human albumin (A9731, Sigma-Aldrich), and 213 ?g mL.sup.?1 L-ascorbic acid 2-phosphate (A8960, Sigma-Aldrich). The culture medium was replaced on alternate days (48 h). At days 0-2, the medium was supplemented with 6 ?M of the glycogen synthase kinase 3-? inhibitor CHIR99021 (SML1046, Sigma-Aldrich). On day 2, the medium was changed to CDM3 supplemented with 2 ?M of the Wnt inhibitor-Wnt-C59 (5.00496.0001, CalBiochem). Day 4 onwards, the cells were cultured in medium without the inhibitors. The beating cells were observed from day 7. At day 10, medium was replaced with RPMI 1640 without glucose (11879020, Gibco), 500 ?g mL.sup.?1 recombinant human albumin, and 213 ?g mL.sup.?1 L-ascorbic acid 2-phosphate supplemented with 4 mM L-lactic acid (71720, Sigma-Aldrich) for metabolic enrichment of cardiomyocytes. The cardiomyocytes were characterized by immunofluorescence staining for sarcomeric alpha actin (ab9465, Abcam) and MYH6 (ab50967, Abcam).
[0073] The differentiation of iPSCs toward neural progenitor cells was carried out using EB method by initiating the treatment with the TGF-beta/Smad inhibitor SB 431542 (16-141, Torcis) for 2 days. The EBs were then plated on polyornithine-coated plates on day 5 (A004, Merck Millipore). The neural rosettes were visually identified at day 7-10. After that, the rosettes were excised and grown on polyornithine-coated plates in STEMPRO NSC SFM kit (A1050901, Gibco). The NPC characterization was carried out by immunostaining for NESTIN (sc-23927, Santa Cruz Biotechnology) and PAX6 (sc-81649, Santa Cruz Biotechnology).
Human Mesenchymal Stem Cells Culture
[0074] Human bone marrow derived mesenchymal stem cells (MSC) were purchased from Lonza (PT 2501, CA10064-080) and cultured in low-glucose DMEM (10567014, Gibco) according to previously published protocols [58].
Cell Proliferation Assay
[0075] Human iPSC-derived fibroblasts, cardiomyocytes and neural progenitor cells were plated on 96-well plates and co-cultured with or without the raw MAX phase and oxidized TTO composites at a concentration of 50 ?g mL.sup.?1 for 24 hours. Then, the cell proliferation was assessed using the WST-1 proliferation kit (K301, BioVision?).
Assessment of Cytotoxicity
[0076] To assess cytotoxicity, human MSC were cultured with different forms of MXene for 24 hours at a concentration of 50 ?g mL.sup.?1. To evaluate cytotoxicity, LDH release from damaged cells (if any) was measured in the supernatant using a Cytotoxicity Detection Kit (MK401, Takara Bio).
Assessment of Cellular Viability Using LIVE/DEAD? Assay
[0077] To assess the effect of TTO MXene on cell viability, LIVE/DEAD? assay was performed. Briefly, human MSC (2?10.sup.5) were plated on 96-well plates and co-cultured with or without the MAX phase and TTO composites for 72 hours. The cells were then stained using a LIVE/DEAD? Viability/Cytotoxicity Kit (L3224, Invitrogen) for 30 min and then visualized using Nikon Eclipse Ti-2 fluorescence microscope. Calcein was detected using the GFP Filter (Ex480/Em535) and EthD-1 was detected using the TRITC Filter (Ex540/Em605).
Statistical Analysis
[0078] Data were reported as mean?SD unless otherwise specified. Comparison of data between multiple groups was performed using one-way analysis of variance (ANOVA) followed by Tukey's post-hoc multiple comparison test, and analysis between two groups was made using Student's t-test (two-tailed). Statistical analysis was performed using GraphPad Prism 8.0.1 (San Diego, USA). Statistical significance was defined as p<0.05.
[0079] While the preferred embodiments of the invention have been described above, it will be recognized and understood that various modifications may be made therein, and the appended claims are intended to cover all such modifications which may fall within the spirit and scope of the invention.
REFERENCES
[0080] [1] W. Gao, S. Emaminejad, H. Y. Y. Nyein, S. Challa, K. Chen, A. Peck, H. M. Fahad, H. Ota, H. Shiraki, D. Kiriya, D.-H. Lien, G. A. Brooks, R. W. Davis, A. Javey, Nature 2016, 529, 509. [0081] [2] J. Kim, G. A. Salvatore, H. Araki, A. M. Chiarelli, Z. Xie, A. Banks, X. Sheng, Y. Liu, J. W. Lee, K.-I. Jang, S. Y. Heo, K. Cho, H. Luo, B. Zimmerman, J. Kim, L. Yan, X. Feng, S. Xu, M. Fabiani, G. Gratton, Y. Huang, U. Paik, J. A. Rogers, Sci. Adv. 2016, 2, e1600418. [0082] [3] J. Liu, T.-M. Fu, Z. Cheng, G. Hong, T. Zhou, L. Jin, M. Duvvuri, Z. Jiang, P. Kruskal, C. Xie, Z. Suo, Y. Fang, C. M. Lieber, Nat. Nanotechnol. 2015, 10, 629. [0083] [4] A. Chortos, J. Liu, Z. Bao, Nat. Mater. 2016, 15, 937. [0084] [5] H. Huang, S. Su, N. Wu, H. Wan, S. Wan, H. Bi, L. Sun, Front. Chem. 2019, 7, 399. [0085] [6] C. Liu, Z. Yu, D. Neff, A. Zhamu, B. Z. Jang, Nano Lett. 2010, 10, 4863. [0086] [7] Y. Rangom, X. Tang, L. F. Nazar, ACS Nano 2015, 9, 7248. [0087] [8] Y. Chen, A. Amiri, J. G. Boyd, M. Naraghi, Adv. Funct. Mater. 2019, 29, 1901425. [0088] [9] X. Chen, R. Paul, L. Dai, Natl. Sci. Rev. 2017, 4, 453. [0089] [10] S. He, Y. Hu, J. Wan, Q. Gao, Y. Wang, S. Xie, L. Qiu, C. Wang, G. Zheng, B. Wang, H. Peng, Carbon N. Y. 2017, 122, 162. [0090] [11] M. Ghidiu, M. R. Lukatskaya, M.-Q. Zhao, Y. Gogotsi, M. W. Barsoum, Nature 2015, 516, 78. [0091] [12] M. Naguib, M. Kurtoglu, V. Presser, J. Lu, J. Niu, M. Heon, L. Hultman, Y. Gogotsi, M. W. Barsoum, Adv. Mater. 2011, 23, 4248. [0092] [13] M. R. Lukatskaya, O. Mashtalir, C. E. Ren, Y. Dall'Agnese, P. Rozier, P. L. Taberna, M. Naguib, P. Simon, M. W. Barsoum, Y. Gogotsi, Science 2013, 341, 1502. [0093] [14] B. Anasori, Y. Xie, M. Beidaghi, J. Lu, B. C. Hosler, L. Hultman, P. R. C. Kent, Y. Gogotsi, M. W. Barsoum, ACS Nano 2015, 9, 9507. [0094] [15] B. Anasori, M. R. Lukatskaya, Y. Gogotsi, Nat. Rev. Mater. 2017, 2, 16098. [0095] [16] K. Huang, Z. Li, J. Lin, G. Han, P. Huang, Chem. Soc. Rev. 2018, 47, 5109. [0096] [17] A. Rafieerad, G. L. Sequiera, W. Yan, P. Kaur, A. Amiri, S. Dhingra, J. Mech. Behav. Biomed. Mater. 2020, 101, 103440. [0097] [18] J. Yang, W. Bao, P. Jaumaux, S. Zhang, C. Wang, G. Wang, Adv. Mater. Interfaces 2019, 6, 1802004. [0098] [19] M. Naguib, O. Mashtalir, M. R. Lukatskaya, B. Dyatkin, C. Zhang, V. Presser, Y. Gogotsi, M. W. Barsoum, Chem. Commun. 2014, 50, 7420. [0099] [20] O. Mashtalir, M. R. Lukatskaya, M.-Q. Zhao, M. W. Barsoum, Y. Gogotsi, Adv. Mater. 2015, 27, 3501. [0100] [21] A. Rafieerad, W. Yan, G. L. Sequiera, N. Sareen, E. Abu-El-Rub, M. Moudgil, S. Dhingra, Adv. Healthc. Mater. 2019, 8, 1900569. [0101] [22] H. Lin, Y. Wang, S. Gao, Y. Chen, J. Shi, Adv. Mater. 2018, 30, 1703284. [0102] [23] C. Dai, Y. Chen, X. Jing, L. Xiang, D. Yang, H. Lin, Z. Liu, X. Han, R. Wu, ACS Nano 2017, 11, 12696. [0103] [24] H. Li, Z. Yao, J. Zhang, X. Cai, L. Li, G. Liu, J. Liu, L. Cui, J. Huang, SN Appl. Sci. 2020, 2, 671. [0104] [25] B. R. Levine, S. Sporer, R. A. Poggie, C. J. Della Valle, J. J. Jacobs, Biomaterials 2006, 27, 4671. [0105] [26] M.-D. Bermddez, F. J. Carri?n, G. Martfnez-Nicol?s, R. L?pez, Wear 2005, 258, 693. [0106] [27] D. M. Findlay, K. Welldon, G. J. Atkins, D. W. Howie, A. C. W. Zannettino, D. Bobyn, Biomaterials 2004, 25, 2215. [0107] [28] Z. Liu, H. Lin, M. Zhao, C. Dai, S. Zhang, W. Peng, Y. Chen, Theranostics 2018, 8, 1648. [0108] [29] G. Deysher, S. Sin, Y. Gogotsi, B. Anasori, Mater. Today 2018, 21, 1064. [0109] [30] B. Ahmed, D. H. Anjum, M. N. Hedhili, Y. Gogotsi, H. N. Alshareef, Nanoscale 2016, 8, 7580. [0110] [31] T. Li, L. Yao, Q. Liu, J. Gu, R. Luo, J. Li, X. Yan, W. Wang, P. Liu, B. Chen, W. Zhang, W. Abbas, R. Naz, D. Zhang, Angew. ChemieInt. Ed. 2018, 57, 6115. [0111] [32] J. Xuan, Z. Wang, Y. Chen, D. Liang, L. Cheng, X. Yang, Z. Liu, R. Ma, T. Sasaki, F. Geng, Angew. Chemie 2016, 128, 14789. [0112] [33] W. Gao, T. Liu, Z. Zhang, M. Dou, F. Wang, J. Mater. Chem. A 2020, 8, 5525. [0113] [34] I. E. Grey, W. G. Mumme, R. S. Roth, J. Solid State Chem. 2005, 178, 3308. [0114] [35] L. Greenspan, J. Res. Natl. Bur. Stand.A. Phys. Chem. 1977, 81A, 89. [0115] [36] R. Syamsai, J. R. Rodriguez, V. G. Pol, Q. Van Le, K. M. Batoo, S. A. Farooq, S. Pandiaraj, M. R. Muthumareeswaran, E. H. Raslan, A. N. Grace, Sci. Rep. 2021, 11, 688. [0116] [37] J. Wang, S. Kaskel, J. Mater. Chem. 2012, 22, 23710. [0117] [38] A. Amiri, Y. Chen, C. B. Teng, M. Naraghi, Energy Storage Mater. 2020, 25, 731. [0118] [39] M. R. Lukatskaya, S.-M. Bak, X. Yu, X.-Q. Yang, M. W. Barsoum, Y. Gogotsi, Adv. Energy Mater. 2015, 5, 1500589. [0119] [40] R. B. Rakhi, B. Ahmed, M. N. Hedhili, D. H. Anjum, H. N. Alshareef, Chem. Mater. 2015, 27, 5314. [0120] [41] B. Jiang, X. Ban, Q. Wang, K. Cheng, K. Zhu, K. Ye, G. Wang, D. Cao, J. Yan, J. Mater. Chem. A 2019, 7, 24374. [0121] [42] Y. Wang, X. Wang, X. Li, Y. Bai, H. Xiao, Y. Liu, G. Yuan, Chem. Eng. J. 2021, 405, 126664. [0122] [43] Z. Wang, S. Qin, S. Seyedin, J. Zhang, J. Wang, A. Levitt, N. Li, C. Haines, R. Ovalle-Robles, W. Lei, Y. Gogotsi, R. H. Baughman, J. M. Razal, Small 2018, 14, 1802225. [0123] [44] S. Richter, M. Daring, M. Ebert, K. Bode, A. M?ssigbrodt, P. Sommer, D. Husser, G. Hindricks, Circulation 2018, 137, 2408. [0124] [45] J. S. Chae, N.-S. Heo, C. H. Kwak, W.-S. Cho, G. H. Seol, W.-S. Yoon, H.-K. Kim, D. J. Fray, A. T. E. Vilian, Y.-K. Han, Y. S. Huh, K. C. Roh, Nano Energy 2017, 34, 86. [0125] [46] I. M. Mosa, A. Pattammattel, K. Kadimisetty, P. Pande, M. F. El-Kady, G. W. Bishop, M. Novak, R. B. Kaner, A. K. Basu, C. V. Kumar, J. F. Rusling, Adv. Energy Mater. 2017, 7, 1700358. [0126] [47] N. Jung, S. Kwon, D. Lee, D.-M. Yoon, Y. M. Park, A. Benayad, J.-Y. Choi, J. S. Park, Adv. Mater. 2013, 25, 6854. [0127] [48] X. Yang, C. Cheng, Y. Wang, L. Qiu, D. Li, Science 2013, 341, 534. [0128] [49] S. Murali, N. Quarles, L. L. Zhang, J. R. Potts, Z. Tan, Y. Lu, Y. Zhu, R. S. Ruoff, Nano Energy 2013, 2, 764. [0129] [50] Y. Zhu, S. Murali, M. D. Stoller, K. J. Ganesh, W. Cai, P. J. Ferreira, A. Pirkle, R. M. Wallace, K. A. Cychosz, M. Thommes, D. Su, E. A. Stach, R. S. Ruoff, Science 2011, 332, 1537. [0130] [51] M. Heon, S. Lofland, J. Applegate, R. Nolte, E. Cortes, J. D. Hettinger, P.-L. Taberna, P. Simon, P. Huang, M. Brunet, Y. Gogotsi, Energy Environ. Sci. 2011, 4, 135. [0131] [52] C. Liu, F. Li, L.-P. Ma, H.-M. Cheng, Adv. Mater. 2010, 22, E28. [0132] [53] C. Couly, M. Alhabeb, K. L. Van Aken, N. Kurra, L. Gomes, A. M. Navarro-Su?rez, B. Anasori, H. N. Alshareef, Y. Gogotsi, Adv. Electron. Mater. 2018, 4, 1700339. [0133] [54] X. Wu, B. Huang, Q. Wang, Y. Wang, Chem. Eng. J. 2020, 380, 122456. [0134] [55] A. Srivastava, G. L. Sequiera, K. N. Alagarsamy, C. Rockman-Greenberg, S. Dhingra, Stem Cell Res. 2021, 53, 102283. [0135] [56] G. L. Sequiera, C. Rockman-Greenberg, S. Dhingra, Stem Cell Res. 2020, 48, 101964. [0136] [57] G. L. Sequiera, A. Srivastava, K. N. Alagarsamy, C. Rockman-Greenberg, S. Dhingra, Cells 2021, 10, 568. [0137] [58] E. Abu-El-Rub, N. Sareen, W. Yan, K. N. Alagarsamy, A. Rafieerad, A. Srivastava, V. Desiderio, S. Dhingra, Cell Death Dis. 2020, 11, 419.